Anfeng Si
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Surgery 12
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
-
- Circular RNAs in diseases 5
- RNA Research and Splicing 2
- RNA modifications and cancer 2
- Co-authors
- Zhengqing Lei (19 shared papers)Wan Yee Lau (12 shared papers)Kui Wang (12 shared papers)Feng Shen (14 shared papers)Yong Xia (10 shared papers)Xuying Wan (7 shared papers)Mengchao Wu (6 shared papers)Dong Wu (5 shared papers)
In The Last Decade
Anfeng Si
31 papers receiving 1.3k citations
Anfeng Si's Hit Papers
Peers
Comparison fields: 5 of 69
- Hepatology 537
- Cancer Research 203
- Surgery 360
- Oncology 172
- Pulmonary and Respiratory Medicine 145
Countries citing papers authored by Anfeng Si
This map shows the geographic impact of Anfeng Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anfeng Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anfeng Si more than expected).
Fields of papers citing papers by Anfeng Si
This network shows the impact of papers produced by Anfeng Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anfeng Si. The network helps show where Anfeng Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Anfeng Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria Hit paper breakdown → | 2015 | 466 |
| 2 | 2019 | 132 | |
| 3 | 2018 | 73 | |
| 4 | 2019 | 61 | |
| 5 | 2020 | 56 | |
| 6 | 2017 | 40 | |
| 7 | 2015 | 38 | |
| 8 | 2018 | 38 | |
| 9 | 2016 | 38 | |
| 10 | 2019 | 37 | |
| 11 | 2017 | 31 | |
| 12 | 2017 | 31 | |
| 13 | 2018 | 27 | |
| 14 | 2017 | 25 | |
| 15 | 2020 | 24 | |
| 16 | 2016 | 23 | |
| 17 | 2019 | 20 | |
| 18 | 2019 | 19 | |
| 19 | 2018 | 16 | |
| 20 | 2023 | 15 |
About Anfeng Si
Anfeng Si is a scholar working on Surgery, Molecular Biology, Hepatology, Cancer Research and Oncology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (5 papers), Liver Disease Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (3 papers), RNA Research and Splicing (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Hepatology (537 citations), Cancer Research (203 citations), Surgery (360 citations), Oncology (172 citations) and Pulmonary and Respiratory Medicine (145 citations). Anfeng Si has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Zhengqing Lei, Wan Yee Lau, Kui Wang, Feng Shen, Yong Xia, Xuying Wan, Mengchao Wu, Dong Wu, Qing Wang and Jun Li. Their work appears in journals such as Gene, Surgery, Frontiers in Oncology, HPB and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.